114 related articles for article (PubMed ID: 35461070)
21. Dysregulated Tgfbr2/ERK-Smad4/SOX2 Signaling Promotes Lung Squamous Cell Carcinoma Formation.
Wang Y; Tan X; Tang Y; Zhang C; Xu J; Zhou J; Cheng X; Hou N; Liu W; Yang G; Teng Y; Yang X
Cancer Res; 2019 Sep; 79(17):4466-4479. PubMed ID: 31209059
[TBL] [Abstract][Full Text] [Related]
22. Insights into the regulatory role and clinical relevance of mediator subunit, MED12, in human diseases.
Srivastava S; Kulshreshtha R
J Cell Physiol; 2021 May; 236(5):3163-3177. PubMed ID: 33174211
[TBL] [Abstract][Full Text] [Related]
23. TGFBR2 mediated phosphorylation of BUB1 at Ser-318 is required for transforming growth factor-β signaling.
Nyati S; Gregg BS; Xu J; Young G; Kimmel L; Nyati MK; Ray D; Speers C; Rehemtulla A
Neoplasia; 2020 Apr; 22(4):163-178. PubMed ID: 32143140
[TBL] [Abstract][Full Text] [Related]
24. Mediator subunit Med12 contributes to the maintenance of neural stem cell identity.
Kim NH; Livi CB; Yew PR; Boyer TG
BMC Dev Biol; 2016 May; 16(1):17. PubMed ID: 27188461
[TBL] [Abstract][Full Text] [Related]
25. Mutations in Exon 1 highlight the role of MED12 in uterine leiomyomas.
Kämpjärvi K; Park MJ; Mehine M; Kim NH; Clark AD; Bützow R; Böhling T; Böhm J; Mecklin JP; Järvinen H; Tomlinson IP; van der Spuy ZM; Sjöberg J; Boyer TG; Vahteristo P
Hum Mutat; 2014 Sep; 35(9):1136-41. PubMed ID: 24980722
[TBL] [Abstract][Full Text] [Related]
26. Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition.
Li LQ; Pan D; Chen Q; Zhang SW; Xie DY; Zheng XL; Chen H
Cell Physiol Biochem; 2018; 47(4):1533-1545. PubMed ID: 29940566
[TBL] [Abstract][Full Text] [Related]
27. Uterine leiomyoma-linked MED12 mutations disrupt mediator-associated CDK activity.
Turunen M; Spaeth JM; Keskitalo S; Park MJ; Kivioja T; Clark AD; Mäkinen N; Gao F; Palin K; Nurkkala H; Vähärautio A; Aavikko M; Kämpjärvi K; Vahteristo P; Kim CA; Aaltonen LA; Varjosalo M; Taipale J; Boyer TG
Cell Rep; 2014 May; 7(3):654-60. PubMed ID: 24746821
[TBL] [Abstract][Full Text] [Related]
28. MED12 overexpression is a frequent event in castration-resistant prostate cancer.
Adler D; Offermann A; Braun M; Menon R; Syring I; Nowak M; Halbach R; Vogel W; Ruiz C; Zellweger T; Rentsch CA; Svensson M; Andren O; Bubendorf L; Biskup S; Duensing S; Kirfel J; Perner S
Endocr Relat Cancer; 2014 Aug; 21(4):663-675. PubMed ID: 24938407
[TBL] [Abstract][Full Text] [Related]
29. Functional similarity between TGF-beta type 2 and type 1 receptors in the female reproductive tract.
Ni N; Fang X; Li Q
Sci Rep; 2021 Apr; 11(1):9294. PubMed ID: 33927274
[TBL] [Abstract][Full Text] [Related]
30. MED12 mutations in human diseases.
Wang H; Shen Q; Ye LH; Ye J
Protein Cell; 2013 Sep; 4(9):643-6. PubMed ID: 23836153
[TBL] [Abstract][Full Text] [Related]
31. GDF15 induced apoptosis and cytotoxicity in A549 cells depends on TGFBR2 expression.
Tarfiei GA; Shadboorestan A; Montazeri H; Rahmanian N; Tavosi G; Ghahremani MH
Cell Biochem Funct; 2019 Jul; 37(5):320-330. PubMed ID: 31172564
[TBL] [Abstract][Full Text] [Related]
32. A novel circ_MACF1/miR-942-5p/TGFBR2 axis regulates the functional behaviors and drug sensitivity in gefitinib-resistant non-small cell lung cancer cells.
Fan D; Yang Y; Zhang W
BMC Pulm Med; 2022 Jan; 22(1):27. PubMed ID: 34996416
[TBL] [Abstract][Full Text] [Related]
33. A TGF-β type II receptor that associates with developmental transition in Haemonchus contortus in vitro.
He L; Gasser RB; Li T; Di W; Li F; Zhang H; Zhou C; Fang R; Hu M
PLoS Negl Trop Dis; 2019 Dec; 13(12):e0007913. PubMed ID: 31790412
[TBL] [Abstract][Full Text] [Related]
34. The E3 ligase HUWE1 mediates TGFBR2 ubiquitination and promotes gastric cancer cell proliferation, migration, and invasion.
He Y; Zhou J; Wan Q
Invest New Drugs; 2021 Jun; 39(3):713-723. PubMed ID: 33405091
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical profiling of receptor tyrosine kinases, MED12, and TGF-βRII of surgically resected small cell lung cancer, and the potential of c-kit as a prognostic marker.
Yokouchi H; Nishihara H; Harada T; Ishida T; Yamazaki S; Kikuchi H; Oizumi S; Uramoto H; Tanaka F; Harada M; Akie K; Sugaya F; Fujita Y; Takamura K; Kojima T; Higuchi M; Honjo O; Minami Y; Watanabe N; Goto A; Suzuki H; Dosaka-Akita H; Isobe H; Nishimura M; Munakata M
Oncotarget; 2017 Jun; 8(24):39711-39726. PubMed ID: 28055980
[TBL] [Abstract][Full Text] [Related]
36. Dual genome-wide CRISPR knockout and CRISPR activation screens identify mechanisms that regulate the resistance to multiple ATR inhibitors.
Schleicher EM; Dhoonmoon A; Jackson LM; Clements KE; Stump CL; Nicolae CM; Moldovan GL
PLoS Genet; 2020 Nov; 16(11):e1009176. PubMed ID: 33137164
[TBL] [Abstract][Full Text] [Related]
37. Vitamin D as an effective treatment in human uterine leiomyomas independent of mediator complex subunit 12 mutation.
Corachán A; Trejo MG; Carbajo-García MC; Monleón J; Escrig J; Faus A; Pellicer A; Cervelló I; Ferrero H
Fertil Steril; 2021 Feb; 115(2):512-521. PubMed ID: 33036796
[TBL] [Abstract][Full Text] [Related]
38. microRNA-301b-3p downregulation underlies a novel inhibitory role of long non-coding RNA MBNL1-AS1 in non-small cell lung cancer.
Li P; Xing W; Xu J; Yuan D; Liang G; Liu B; Ma H
Stem Cell Res Ther; 2019 May; 10(1):144. PubMed ID: 31113460
[TBL] [Abstract][Full Text] [Related]
39. MED12 mutations in breast phyllodes tumors: evidence of temporal tumoral heterogeneity and identification of associated critical signaling pathways.
Laé M; Gardrat S; Rondeau S; Richardot C; Caly M; Chemlali W; Vacher S; Couturier J; Mariani O; Terrier P; Bièche I
Oncotarget; 2016 Dec; 7(51):84428-84438. PubMed ID: 27806318
[TBL] [Abstract][Full Text] [Related]
40. SILAC-Based Quantification of TGFBR2-Regulated Protein Expression in Extracellular Vesicles of Microsatellite Unstable Colorectal Cancers.
Fricke F; Michalak M; Warnken U; Hausser I; Schnölzer M; Kopitz J; Gebert J
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31454892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
